3625 results

Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: vascular healing outcomes from the MAGSTEMI trial

27 Dec 2020

The MAGSTEMI trial showed larger endothelium-independent vasodilatation with magnesium-based bioresorbable scaffolds (MgBRS) than with sirolimus-eluting stents (SES). However, restenosis was more frequent with MgBRS. The aims of this study were to compare the healing pattern between MgBRS and SES and to describe the main causes of...

Authors :

J. Gomez-Lara, L. Ortega-Paz, S. Brugaletta, J. Cuesta, S. Romaní, A. Serra, P. Salinas, B. García del Blanco, J. Goicolea, R. Hernandez-Antolín, P. Antuña, R. Romaguera, A. Regueiro, F. Rivero, Àngel Cequier, F. Alfonso, J.Antoni Gómez-Hospital, M. Sabaté

On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

05 Mar 2023

Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).

Author

Mirvat Alasnag

Frequency and safety of bioprosthetic valve fracture in patients undergoing valve in valve TAVR for failed surgical valves using the SAPIEN 3/Ultra Valves: Insights from real-world data

19 Sep 2022

Michele Pighi provides his take on this trial which aimed to compare the safety and efficacy of VIV-TAVI with or without bioprosthetic valve fracture. It was presented by Santiago Garcia during the TCT Congress 2022.

Author

Michele Pighi

Elixir Medical completes enrollment in BIOADAPTOR randomized controlled trial of Dynamx Coronary Bioadaptor System

15 Feb 2022

Dynamx bioadaptor restores rotational motion and vessel stress reduction in new study

02 Jun 2022